Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 2 diabetes
Pharma
Novo Nordisk's weekly insulin will get FDA adcomm review
The FDA will convene a panel of experts on May 24 to provide guidance on Novo Nordisk's application for once-weekly insulin Awiqli (icodec).
Kevin Dunleavy
Apr 29, 2024 11:08am
Export of Novo Nordisk's Ozempic could be banned in Germany
Nov 15, 2023 11:07am
CEO: Lilly 'aggressively planning' Mounjaro supply expansions
Nov 2, 2023 10:05am
EU, UK authorities flag fake versions of Novo's Ozempic
Oct 19, 2023 10:15am
Novo stops semaglutide CKD trial early on strong interim data
Oct 11, 2023 11:18am
In push to boost Kerendia, Bayer adds 3 heart failure trials
Sep 1, 2023 11:03am